ArticleJournal of neurology2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.
Charlotte Héraud et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it